Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-05-14 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
S | Common Stock | D | 3000 | $7.99 - $7.99 | $23,970 |
| 2024-05-03 | ARDELYX, INC. | GRAMMER ELIZABETH A
(See Remarks) |
S | Common Stock | D | 45000 | $9.00 - $9.00 | $405,000 |
| 2024-05-03 | ARDELYX, INC. | Williams Laura A
(Chief Medical Officer) |
S | Common Stock | D | 39949 | $8.35 - $8.35 | $333,574 |
| 2024-05-03 | ARDELYX, INC. | Williams Laura A
(Chief Medical Officer) |
M | Common Stock | A | 30000 | $0.99 - $0.99 | $29,700 |
| 2024-04-29 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
S | Common Stock | D | 30000 | $6.40 - $6.40 | $192,057 |
| 2024-04-29 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
M | Common Stock | A | 30000 | $0.99 - $0.99 | $29,700 |
| 2024-03-25 | ARDELYX, INC. | Kelliher Mike
(See Remarks) |
A | Common Stock | A | 160000 | $0.00 - $0.00 | $0 |
| 2024-03-15 | ARDELYX, INC. | Blanks Robert
(See Remarks) |
G | Common Stock | D | 1000 | $0.00 - $0.00 | $0 |
| 2024-03-20 | ARDELYX, INC. | GRAMMER ELIZABETH A
(See Remarks) |
S | Common Stock | D | 86000 | $7.73 - $7.73 | $664,977 |
| 2024-02-26 | ARDELYX, INC. | Rosenbaum David P.
(Chief Development Officer) |
S | Common Stock | D | 5183 | $9.20 - $9.20 | $47,683 |
| 2024-02-20 | ARDELYX, INC. | Rosenbaum David P.
(Chief Development Officer) |
S | Common Stock | D | 7311 | $8.75 - $8.75 | $63,944 |
| 2024-02-20 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
S | Common Stock | D | 22917 | $8.75 - $8.75 | $200,438 |
| 2024-02-20 | ARDELYX, INC. | Blanks Robert
(See Remarks) |
S | Common Stock | D | 5017 | $8.75 - $8.75 | $43,880 |
| 2024-02-20 | ARDELYX, INC. | GRAMMER ELIZABETH A
(See Remarks) |
S | Common Stock | D | 4432 | $8.75 - $8.75 | $38,763 |
| 2024-02-20 | ARDELYX, INC. | Rodriguez Susan
(Chief Commercial Officer) |
S | Common Stock | D | 6928 | $8.75 - $8.75 | $60,594 |
| 2024-02-20 | ARDELYX, INC. | Felsch Robert Ora
(See Remarks) |
S | Common Stock | D | 2352 | $8.75 - $8.75 | $20,571 |
| 2024-02-20 | ARDELYX, INC. | Williams Laura A
(Chief Medical Officer) |
S | Common Stock | D | 4803 | $8.75 - $8.75 | $42,008 |
| 2024-01-16 | ARDELYX, INC. | Williams Laura A
(Chief Medical Officer) |
A | Common Stock | A | 118750 | $0.00 - $0.00 | $0 |
| 2024-01-16 | ARDELYX, INC. | Rosenbaum David P.
(Chief Development Officer) |
A | Common Stock | A | 182870 | $0.00 - $0.00 | $0 |
| 2024-01-16 | ARDELYX, INC. | Rodriguez Susan
(Chief Commercial Officer) |
A | Common Stock | A | 112750 | $0.00 - $0.00 | $0 |
| 2024-01-16 | ARDELYX, INC. | Renz Justin A
(Chief Financial Officer) |
A | Common Stock | A | 127750 | $0.00 - $0.00 | $0 |
| 2024-01-16 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
A | Common Stock | A | 475000 | $0.00 - $0.00 | $0 |
| 2024-01-16 | ARDELYX, INC. | GRAMMER ELIZABETH A
(See Remarks) |
A | Common Stock | A | 127750 | $0.00 - $0.00 | $0 |
| 2024-01-08 | ARDELYX, INC. | Rosenbaum David P.
(Chief Development Officer) |
S | Common Stock | D | 30000 | $6.64 - $6.64 | $199,200 |
| 2023-12-26 | ARDELYX, INC. | Renz Justin A
(Chief Financial Officer) |
S | Common Stock | D | 225000 | $6.36 - $6.36 | $1,430,122 |
| 2023-12-26 | ARDELYX, INC. | Renz Justin A
(Chief Financial Officer) |
M | Common Stock | A | 75000 | $0.99 - $0.99 | $74,250 |
| 2023-12-18 | ARDELYX, INC. | Rosenbaum David P.
(Chief Development Officer) |
S | Common Stock | D | 5675 | $6.07 - $6.07 | $34,447 |
| 2023-12-14 | ARDELYX, INC. | Rosenbaum David P.
(Chief Development Officer) |
S | Common Stock | D | 7000 | $5.55 - $5.55 | $38,850 |
| 2023-12-11 | ARDELYX, INC. | GRAMMER ELIZABETH A
(See Remarks) |
S | Common Stock | D | 50000 | $5.08 - $5.08 | $253,925 |
| 2023-12-05 | ARDELYX, INC. | Rosenbaum David P.
(Chief Development Officer) |
S | Common Stock | D | 10272 | $5.00 - $5.00 | $51,360 |
| 2023-11-30 | ARDELYX, INC. | Rosenbaum David P.
(Chief Development Officer) |
S | Common Stock | D | 3000 | $4.50 - $4.50 | $13,500 |
| 2023-11-20 | ARDELYX, INC. | Williams Laura A
(Chief Medical Officer) |
S | Common Stock | D | 2581 | $4.36 - $4.36 | $11,258 |
| 2023-11-20 | ARDELYX, INC. | Rosenbaum David P.
(Chief Development Officer) |
S | Common Stock | D | 3767 | $4.36 - $4.36 | $16,431 |
| 2023-11-20 | ARDELYX, INC. | Rodriguez Susan
(Chief Commercial Officer) |
S | Common Stock | D | 4714 | $4.36 - $4.36 | $20,563 |
| 2023-11-20 | ARDELYX, INC. | Renz Justin A
(Chief Financial Officer) |
S | Common Stock | D | 2873 | $4.36 - $4.36 | $12,532 |
| 2023-11-20 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
S | Common Stock | D | 11368 | $4.36 - $4.36 | $49,589 |
| 2023-11-20 | ARDELYX, INC. | GRAMMER ELIZABETH A
(See Remarks) |
S | Common Stock | D | 2384 | $4.36 - $4.36 | $10,399 |
| 2023-11-20 | ARDELYX, INC. | Felsch Robert Ora
(See Remarks) |
S | Common Stock | D | 1044 | $4.36 - $4.36 | $4,554 |
| 2023-11-20 | ARDELYX, INC. | Blanks Robert
(See Remarks) |
S | Common Stock | D | 2835 | $4.36 - $4.36 | $12,366 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |